#BreastCancer Archives

ESMO 2023 | Professor Man Li: Dato-DXd Multidomain Efficacy Data Released, Bringing Hope for Survival to More Cancer Patients

By Mourabit Halima 2024.01.20

Editor's note: Currently, antibody-drug conjugates (ADCs) have become "star drugs" in the field of cancer treatment. Dato-DXd is a novel ADC that consists of a humanized monoclonal antibody targeting Trop-2,…

ASCO China Voice | Professor Jiang Zefei: Progress or Decrease in Risk of Death by 35%, TORCHLIGHT Shines Light on Chinese TNBC

By Mourabit Halima 2024.01.14

On June 3rd, at 5:00 PM local time (6:00 AM Beijing time on June 4th), during the American Society of Clinical Oncology (ASCO) annual meeting, Professor Liu Qiang from Sun…

Professor Jiang Zefei: Advances in the Treatment of Triple-Negative Breast Cancer

By Mourabit Halima 2024.01.14

Editor's Note: Triple-negative breast cancer (TNBC) refers to a subtype of breast cancer where the tumor cells lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth…